Seaport Therapeutics - Advancing novel antidepressants and anxiolytics

Showcasing Seaport’s Innovative Approach to Mental Health
We’ve developed this website to communicate Seaport’s groundbreaking work in advancing novel antidepressants and anxiolytics. Powered by their Glyph™ platform, Seaport’s therapeutics are uniquely designed to enable oral bioavailability, avoid first-pass metabolism, and reduce hepatotoxicity and other side effects, making them a major advancement in the treatment of mental health conditions.

Leveraging Technology for Clinical Success
Seaport’s proven strategy focuses on advancing clinically validated mechanisms that were previously limited by technological barriers. With the help of their innovative platform, Seaport can now overcome these limitations, opening new possibilities for patients. Through effective messaging, we’ve ensured that Seaport’s technological advancements and vision are clearly communicated to their audience.